176168-85-7

Upstream product

• 176168-83-5 4-(1,3-Dioxolan-2-yl)-3-oxabutyl 2-O-acetyl-3,4-di-O-benzyl-α-L-rhamnopyranoside 
• 167013-82-3 2-O-acetyl-3,4-di-O-benzyl-α-L-rhamnopyranosyl trichloroacetimidate 
• 73983-19-4 1,2-di-O-acetyl-3,4-di-O-benzyl-6-deoxy-α-L-mannopyranose 
• 69980-52-5 2,3,4-tri-O-acetyl-L-rhamnopyranosyl bromide 
• 176168-84-6 4-(1,3-Dioxolan-2-yl)-3-oxabutyl 3,4-di-O-benzyl-α-L-rhamnopyranoside 

Downstream Products

• 176168-86-8 4-(1,3-Dioxolan-2-yl)-3-oxabutyl 3,4-di-O-benzyl-2-O-[3,4-di-O-benzyl-2-O-(2-O-acetyl-3,4-di-O-benzyl-α-L-rhamnopyranosyl)-α-L-rhamnopyranosyl]-α-L-rhamnopyranoside 

Relevant academic research and scientific papers

Synthesis of the trisaccharide α-L-Rha-(1-2)-α-L-Rha-(1-2)-α-L-Rha with a dioxolane-type spacer-arm

The trisaccharide α-L-Rha-(1-2)-α-L-Rha-(1-2)-α-L-Rha with a dioxolane-type spacer was obtained by using the trichloroacetimidate method in all of the glycosidation steps. After deprotection, the trisaccharide was coupled to BSA or KLH by reductive aminat